Lanying Du to HIV-1
This is a "connection" page, showing publications Lanying Du has written about HIV-1.
Connection Strength
0.205
-
A Peptide-Based HIV-1 Fusion Inhibitor with Two Tail-Anchors and Palmitic Acid Exhibits Substantially Improved In Vitro and Ex Vivo Anti-HIV-1 Activity and Prolonged In Vivo Half-Life. Molecules. 2019 Mar 21; 24(6).
Score: 0.066
-
HIV-1 gp41-targeting fusion inhibitory peptides enhance the gp120-targeting protein-mediated inactivation of HIV-1 virions. Emerg Microbes Infect. 2017 Jun 21; 6(6):e59.
Score: 0.058
-
Anti-HIV antibody and drug combinations exhibit synergistic activity against drug-resistant HIV-1 strains. J Infect. 2017 07; 75(1):68-71.
Score: 0.057
-
Improved Pharmacological and Structural Properties of HIV Fusion Inhibitor AP3 over Enfuvirtide: Highlighting Advantages of Artificial Peptide Strategy. Sci Rep. 2015 Aug 19; 5:13028.
Score: 0.013
-
A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV. Virol J. 2013 Aug 26; 10:266.
Score: 0.011